Monthly Archives: March 2019

Recently Published Resources on Falls Prevention – In the Community and in Hospitals (BMJ / NHS Improvement / NIHR / JAMA Internal Medicine)

Posted on March 31, 2019 by Dementia and Elderly Care News

Summary There are uncertainties about the effectiveness of environmental interventions to reduce risk of falls among older persons living in the community. A BMJ systematic review covers the options, coming down in favour of occupational therapist-led environment risk assessments and … Continue reading →

Posted in Acute Hospitals, Assistive Technology, Commissioning, Community Care, Falls, Falls Prevention, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), Integrated Care, International, Management of Condition, National, NHS, NHS Improvement, NICE Guidelines, NIHR, Non-Pharmacological Treatments, Person-Centred Care, Personalisation, Quick Insights, Royal College of Physicians, Systematic Reviews, UK, Universal Interest | Tagged Antipsychotics in People With Dementia: Key Therapeutic Topic [KTT7], Australia, BMJ, BMJ Publishing Group Ltd, British Medical Journal (BMJ), CareFall: Reducing Inpatient Falls Risk and Improving Post Fall Care, College of Healthcare Sciences, Community-Based Care, Community-Based Care for People With Dementia, Community-Based Support, Community-Dwelling Older Adults, Delirium: Prevention Diagnosis and Management: NICE Clinical Guideline (CG103), Department of Health Sciences: University of York, Environmental Assessment and Modification, Environmental Intervention to Reduce Risk of Falls, Evaluation of FallSafe Quality Improvement Project, Falls and Fractures, Falls and Musculoskeletal Health, Falls Assessment, Falls in Hospitals, Falls in Older People, Falls in Older People (NICE Quality Standard: QS86), Falls Prevention Programmes, Falls Reduction, Falls Reduction in Community Dwelling Older Adults, Falls Reduction in Hospitals, Falls Risk Factors, FallSafe Project, FallSafe Quality Improvement Project, FallSafe: Care Bundles to Reduce Inpatient Falls, France, Gerontopole of Toulouse: Toulouse University Hospital, Home Adaptations, Home Modifications, Hospital Falls Prevention, Housing Adaptations, Housing Modifications, Improving Post-Fall Care (CareFall), Incidence and Costs of Inpatient Falls in Hospitals, Inpatient Falls, Institute of Ageing: Toulouse University Hospital, JAMA Internal Medicine, James Cook University (Queensland), Later Life, Leicestershire Partnership NHS Trust, Long-Term Exercise Programmes, Mackay Base Hospital (Queensland), Mackay Institute of Research and Innovation: James Cook University (Queensland), Mental Health Services for Older People: Leicestershire Partnership NHS Trust, Multi-Factorial Falls Assessments and Care Plans, Multifactorial Interventions (Falls), Musculo-Skeletal Disorders, National Audit of Inpatient Falls (NAIF), National Audit of Inpatient Falls Audit Report 2017, NHS Improvement Falls Collaborative Clinical Updates, NICE Clinical Gguidance 161 (CG161), NICE Clinical Guideline CG103, NICE Key Therapeutic Topic [KTT7], NIHR Signal, Nottingham University Hospitals NHS Trust, Occupational Therapist Led Environmental Assessment and Modification, Occupational Therapists, Occupational Therapy Intervention Study (OTIS), Patient Falls Improvement Collaborative, Physical Activity, Physical Activity Programmes, Physical Exercise Programmes, Preventing Falls In Older People Living in the Community, Queensland Health: Mackay Base Hospital, Risk Factors for Falls, Royal College of Physicians (RCP), School of Health Sciences: University of Nottingham, Toulouse University Hospital (CHU Toulouse), University of Nottingham, University of Oxford, University of Toulouse, University of York, UPS/Inserm: University of Toulouse, York Trials Unit: University of York | Leave a comment

NICE Update on Antipsychotics for People With Dementia (NICE)

Posted on March 28, 2019 by Dementia and Elderly Care News

Summary The National Institute for Health and Care Excellence (NICE) has again updated their summary of evidence on the use (or withdrawal) of antipsychotics for people living with dementia. This document is not a formal NICE guideline. Full Text Link … Continue reading →

Posted in Acute Hospitals, Antipsychotics, Commissioning, Community Care, Falls Prevention, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), Integrated Care, Management of Condition, Mental Health, Models of Dementia Care, National, Non-Pharmacological Treatments, Person-Centred Care, Pharmacological Treatments, Quick Insights, SCIE, Systematic Reviews, UK, Universal Interest | Tagged Alive Approach to Provision of Meaningful Activities for Older People Living in Care, Alternatives to Antipsychotic Drugs, Alternatives to Antipsychotic Medication, Antipsychotic Drugs, Antipsychotic Prescribing in Primary Care, Antipsychotics, Antipsychotics and Risk of Venous Thromboembolism, Antipsychotics in Elderly People with Dementia, Antipsychotics in People With Dementia, Antipsychotics in People With Dementia: Key Therapeutic Topic [KTT7], Antipsychotics Limitation in Dementia, Antipsychotics-Related Mortality Risks, Atypical Antipsychotics, Avoidable Harm, Avoidable Mortality, Behavioural and Psychological Symptoms of Dementia (BPSD), Inappropriate Use of Antipsychotics in Dementia, Later Life, Long Term Plan (LTP), Medicines Optimisation, Mellifont Abbey Residential Care Home, Mental Health and Illness, Milton Keynes Primary Care Trust, National Institute for Health and Care Excellence (NICE), National Institute for Health and Care Excellence (NICE)’s Quality Standard on Dementia: 2019 Draft For Consultation, Neurological Disorders, NHS England Medicines Optimisation Intelligence Group, NICE Key Therapeutic Topic [KTT7], NICE Key Therapeutic Topics, Potential Harms of Antipsychotic Use, Prescribing of Antipsychotic Drugs For People With Dementia, Prevalence of Potentially Inappropriate Prescribing of Antipsychotic Drugs, Reducing Antipsychotic Prescriptions in Dementia, Reducing Inappropriate Use of Antipsychotics in Dementia, Social Care Institute for Excellence (SCIE) | Leave a comment

Hippocampal Neurogenesis Life-Long (BBC News / Nature Medicine)

Posted on March 27, 2019 by Dementia and Elderly Care News

Summary Contrary to popular belief, the creation of new brain cells persists throughout life (in the hippocampus at least); although the rate of neurogenesis may decline with old age, and fall massively in Alzheimer’s Disease. Full Text Link Reference Gallagher, … Continue reading →

Posted in BBC News, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, Quick Insights, Universal Interest | Tagged Adult Hippocampal Neurogenesis (AHN), Alzheimer’s Disease, BBC Health News, CBMSO: Centro de Biología Molecular 'Severo Ochoa' (Madrid), Center for Networked Biomedical Research on Neurodegenerative Diseases (CIBERNED), CIEN Foundation (Madrid), Department of Molecular Biology: Universidad Autónoma de Madrid, Department of Molecular Neuropathology: Centro de Biología Molecular 'Severo Ochoa', Faculty of Biomedical and Health Sciences: Universidad Europea de Madrid, Hippocampal Neurogenesis, Hippocampus, Hippocampus-Dependent Cognitive Decline, Hippocampus-Dependent Memory Deficits, Memory Problems, Nature Medicine, Neurodegeneration, Neurodegenerative Disease Research, Neurodegenerative Diseases, Neuronal Creation, Neuronal Loss, Neuropathology Department: CIEN Foundation, New Neurons in Brain, Spain, Universidad Autónoma de Madrid, Universidad Europea de Madrid | Leave a comment

State of Ageing in 2019 Report (Centre for Ageing Better)

Posted on March 25, 2019 by Dementia and Elderly Care News

Summary The Centre for Ageing Better’s latest report investigates many aspects of ageing and increasing longevity. It uses wide-ranging statistics and other evidence to provide: “…a snapshot of what life is like for people aged 65 and older today. It … Continue reading →

Posted in Charitable Bodies, Community Care, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), Housing, Integrated Care, Quick Insights, Statistics, Universal Interest | Tagged Absolute Number of Years Lost to Disability as Life Expectancy Rises, Affluence and Health Inequalities, Age-Associated Decline, Age-Creativity Curve, Ageing, Ageing and Long-Term Care, Ageing and Society, Ageing Policy in Europe, Ageing Policy in the UK, Ageing Population, Ageing Research, American Immortals, Centre for Ageing Better, Centre for Ageing Better (CfAB), Communities, Compression of Morbidity, Epidemiology, Epidemiology and Statistics, Ethical Dilemmas, Ethics and Society, Ezekiel Emanuel: Department of Medical Ethics and Health Policy at University of Pennsylvania, Ezekiel Emanuel: Director of Clinical Bioethics Department at US National Institutes of Health, Ezekiel Emanuel: Doctor and Medical Ethicist, Finances, Health Inequalities, Health Inequalities in England, Health Inequalities: Ethnicity, Health Inequality Monitoring, Living Too Long, Longevity, Low Income and Health Inequalities, MIT Technology Review, National Conversation About Health Inequalities, Personal Finances, Social Epidemiology, The Atlantic (Magazine), Wellbeing and Longevity | Leave a comment

Pharmacists’ Interventions to Promote Quality of Life and Healthy Ageing (PHE)

Posted on March 24, 2019 by Dementia and Elderly Care News

Summary Interventions which can be provided by pharmacy teams to help older people lead more independent lives and improve their health are listed, including those directed towards: Preventing falls. Dementia Physical inactivity. Social isolation. Malnutrition. Full Text Link Reference A … Continue reading →

Posted in Commissioning, Community Care, Diagnosis, Falls, Falls Prevention, For Carers (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), Integrated Care, Management of Condition, Mental Health, Models of Dementia Care, Non-Pharmacological Treatments, Person-Centred Care, Pharmacological Treatments, Public Health England, Quick Insights, Standards, UK, Universal Interest | Tagged Alcohol, Alcohol or Substance Misuse, Blood Pressure and Atrial Fibrillation, Centre for Pharmacy Postgraduate Education (CPPE), Commissioning Community Pharmacy, Commissioning of Pharmacy Services, Community Pharmacies, Community Pharmacies: Promoting Health and Wellbeing. NICE Guideline [NG102] (NICE), Community Pharmacists, Community Pharmacy, Community Pharmacy and Public Health, Community Pharmacy Teams, Community Pharmacy: Interventions for Public Health, Community Pharmacy: Public Health Interventions, Contribution Community Pharmacy to Public Health, Dementia Friendly Pharmacy Practice: Seven Steps, Dementia Friendly Pharmacy Practices, Dementia Risk Reduction, Dementia-Friendly Community Pharmacies, Dementia-Friendly Pharmacies, Diet and Nutrition, Diet and Obesity, Dorset’s Nutritional Care Strategy for Adults, Eatwell Guide For Healthy Eating, Elderly Malnutrition, Falls and Musculoskeletal Health, Five Ways to Wellbeing Framework, Health and Quality of Life, Healthy Ageing, Healthy Ageing: Pharmacist Interventions for Quality of Life, Healthy Living Pharmacies (HLPs), Hypertension, Improving Public Mental Health, Improving Referral Pathways, Later Life, Local Medical Committees (LMCs), Local Pharmaceutical Committees (LPCs), Local Professional Networks (LPNs), Loneliness and Social Isolation, Making Every Contact Count (MECC), Malnutrition, Malnutrition in Later Life, Malnutrition in the Community, MECC Plus, Menu of Interventions (MOIs) for Productive Healthy Ageing, NHS Health Check Programme, NHS Long Term Plan (2019), Oral Health, Pharmacies, Pharmacist Interventions for Quality of Life, Pharmacist Involvement, Pharmacy for Public Health, Pharmacy Teams in Different Settings, PHE: Public Health England, Physical Activity, Physical Activity and Health Benefits, Physical Activity Guidelines for Adults, Physical Activity Recommendations, Physical Inactivity, Primary Care Network (PCN) Contract, Productive Healthy Ageing: Pharmacist Interventions for Quality of Life, Public Health, Public Health England (PHE), Public Mental Health, Quality of Life, Quality of Life For Older People, Reablement Services, Reducing Social Isolation, Seven Steps to Becoming a Dementia Friendly Pharmacy Practice, Social Connectedness, Social Isolation, Substance Misuse, Tackling Loneliness and Social Isolation: Role of Pharmacists, Tobacco | Leave a comment

Smell Test for Early Detection of Parkinson’s Disease (BBC News)

Posted on March 21, 2019 by Dementia and Elderly Care News

Summary Parkinson’s Disease has a distinctive odour for certain gifted individuals, which has been analysed chemically and may now be replicated for automated detection by machine. This may, in future, permit earlier diagnosis and open the possibilities for timely treatments … Continue reading →

Posted in BBC News, Diagnosis, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, Parkinson's Disease, Quick Insights, Scotland, UK, Universal Interest | Tagged ACS Central Science (Journal), Anatune (Cambridge UK), BBC Health News, BBC Scotland News, Biomarkers, Biomarkers Predicting Parkinson's Disease, Department of Biochemistry: University of Liverpool, Department of Neurology: Salford Royal Foundation Trust, Early Diagnosis, Early Diagnosis of Parkinson’s Disease, Edinburgh University, Eicosane, Hyperosmic Super Smeller, Institute for Stem Cell Research: University of Edinburgh, Institute of Integrative Biology: University of Liverpool, Joy Milne, Les Milne, Manchester Academic Health Science Centre: University of Manchester, Neurodegeneration, Neurodegenerative Disease Research, Neurodegenerative Diseases, Non-Invasive Biomarkers, Odour, Parkinson's Disease Smell Test, Parkinson’s Disease Sebum Volatilome, Parkinson’s UK, Perillic Aldehyde, Rapid Screening, Salford Royal Foundation Trust, School of Biological Sciences: University of Edinburgh, Sebum, Smell Test for Parkinson's Disease Diagnosis, Timely / Preclinical Parkinson's Disease Diagnosis, Timely Diagnosis, University of Edinburgh, University of Liverpool, University of Manchester, Volatile Biomarkers of Parkinson’s Disease, Volatilome | Leave a comment

Eye Tests for Early Detection of Alzheimer’s Disease? (NHS Digital / Ophthalmology Retina)

Posted on March 20, 2019 by Dementia and Elderly Care News

Summary Further discussion about the possibilities of using inexpensive eye tests to detect Alzheimer’s Disease, perhaps years before symptoms appear. This particular technique involves the examination of blood vessels and blood flow in the retina, as detected by Octa (Optical … Continue reading →

Posted in Diagnosis, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, NHS Digital (Previously NHS Choices), Quick Insights, Universal Interest | Tagged Alzheimer's Disease: Diagnosis, Alzheimer’s Disease, Alzheimer’s Disease and Dementia, Alzheimer’s Disease Biomarkers, Assessment and Diagnosis, Bazian, Behind the Headlines, Biomarkers, Biomarkers Predicting Cognitive Decline and Alzheimer's Disease, Central Subfield Thickness (CST), Cognitive Impairment, Critical Appraisals, Dementia Case Finding, Dementia Diagnosis, Dementia Screening, Diagnosis, Diagnosis of Alzheimer's Disease, Diagnostics, Duke University in North Carolina, Early Diagnosis, Early Diagnosis of Alzheimer's Disease, Early Treatment Diabetic Retinopathy Study, Eye Examinations, Foveal Avascular Zone (FAZ) Area, Karen L. Wrenn Alzheimer's Disease Award, Macular Ganglion Cell-Inner Plexiform Layer (GC-IPL), MCI: Mild Cognitive Impairment, Mild Cognitive Impairment, National Institutes of Health, National Institutes of Health (NIH), National Institutes of Health (US), Neurodegeneration, Neurodegenerative Disease Research, Neurodegenerative Diseases, NHS Digital (Formerly NHS Choices), Non-Invasive Biomarkers, Octa: Optical Coherence Tomography Angiography, Ophthalmology Retina, Optical Coherence Tomography, Optical Coherence Tomography Angiography (OCTA), Preclinical Alzheimer's Disease, Rapid Screening, Research to Prevent Blindness Inc. (New York), Retina as Early Biomarker of Neurodegeneration, Retinal Biomarkers, Retinal Examination in Neurodegenerative Diseases, Retinal Microvascular and Neurodegenerative Changes in Alzheimer’s Disease, Retinal Microvascular and Neurodegenerative Changes in Mild Cognitive Impairment, Retinal Vessel Density (VD), Screening, Screening for Dementia, Timely Diagnosis, US National Institutes of Health (NIH), USA | Leave a comment

Monthly Archives: March 2019

Hippocampal Neurogenesis Life-Long (BBC News / Nature Medicine)

Smell Test for Early Detection of Parkinson’s Disease (BBC News)

Eye Tests for Early Detection of Alzheimer’s Disease? (NHS Digital / Ophthalmology Retina)

Recent Posts

Archives

Categories

Google Translate (100+ Languages)

Recommended Sites